Use of AI to develop health economic evidence for optimized patient access
For a thorough understanding of the AI journey in healthcare, and its potential to transform and improve evidence generation and market access, listen to Rito Bergemann, MD, PhD and Jacqueline Vanderpuye-Orgle, MSc, PhD in their HEOR Theater presentation at the ISPOR US event. AI and human intelligence will play an integral part in RWD analysis and HEOR evidence, and they discuss its growing importance for optimized patient access.
Related Insights
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Article
Parexel principles for artificial intelligence (AI)
Mar 6, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Blog
Summary and assessment of EMA’s reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle
Mar 7, 2024
Blog
Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)
Mar 7, 2024
Blog
AI Milestones: FDA’s ISTAND program accepts AI-based assessment tool for depression
Mar 19, 2024
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Related Insights
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Article
Parexel principles for artificial intelligence (AI)
Mar 6, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Blog
Summary and assessment of EMA’s reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle
Mar 7, 2024
Blog
Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)
Mar 7, 2024
Blog
AI Milestones: FDA’s ISTAND program accepts AI-based assessment tool for depression
Mar 19, 2024
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021